METHESYS
DEAD

Serial Number

78047465

Owner

ARTEMIS Pharmaceuticals GmbH

Attorney

Peter M. Ferrell III

Filing Date

Feb 9, 2001

Add to watchlist:

No watchlists yet
View on USPTO

METHESYS Trademark

Serial Number: 78047465 • Registration: 2690912

METHESYS is a trademark filed by ARTEMIS Pharmaceuticals GmbH on February 9, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ARTEMIS Pharmaceuticals GmbH (3 trademarks)

Neurather Ring 1
51063 Koln , DE

Entity Type: 03

Trademark Details

Filing Date

February 9, 2001

Registration Date

February 25, 2003

Published for Opposition

December 3, 2002

Cancellation Date

October 3, 2009

Goods & Services

Training services for research and development in the field of genetic pharmacology

Pharmaceutical, veterinary and sanitary preparations, especially preparations which can be obtained by biochemical and microbiological methods, namely medical diagnostic reagents for use in cancer research, infectious disease research and immunology and medicaments for use in the treatment and prevention of cancer, autoimmune and infectious diseases; chemical products containing antibodies, enzymes, nucleic acids and biochemical solutions for laboratory use and clinical diagnostic use in the field of human and veterinary molecular biology, genetic engineering and bioengineering in the research and diagnosis of cancerous and infectious conditions

Chemical products used in industry and science, especially products which can be obtained by biochemical and microbiological methods, namely proteins, nucleic acids, and nucleic acids organized in specific sequences corresponding to the genetic code for the linear order of amino acids in cells for the manufacture, research and development of vaccines and gene and cell therapy products; and chemical products containing antibodies, enzymes, nucleic acids and biochemical solutions for medical and scientific research use and clinical diagnostic use in the field of human and veterinary molecular biology, genetic engineering and bioengineering in the research and diagnosis of cancerous and infectious conditions

Scientific research; industrial research in the field of genetic engineering; providing technical consultation and scientific research management consultation in the field of biotechnology, genetics, molecular biology and genome research for the preparation of analytical, diagnostic and therapeutical agents

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 3, 2009 C8..
CASE FILE IN TICRS
Feb 19, 2008 CFIT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 8, 2004 TCCA
REGISTERED-PRINCIPAL REGISTER
Feb 25, 2003 R.PR
PUBLISHED FOR OPPOSITION
Dec 3, 2002 PUBO
NOTICE OF PUBLICATION
Nov 13, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2002 CNSA
ASSIGNED TO EXAMINER
Sep 27, 2002 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2002 CRFA
PAPER RECEIVED
Jul 15, 2002 MAIL
FINAL REFUSAL MAILED
Apr 29, 2002 CNFR
Sec. 1(B) CLAIM DELETED
Jan 7, 2002 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2002 CRFA
NON-FINAL ACTION MAILED
Jul 3, 2001 CNRT
ASSIGNED TO EXAMINER
Jul 1, 2001 DOCK
ASSIGNED TO EXAMINER
Jun 25, 2001 DOCK